News

Government banned fixed-dose combination drugs citing health ‘risk’

A news has hit the web that Govb is grouping 14 fixed dose combination drugs including Nimesulide and Paracetamol. This news is spread on the web and attracts people’s attention. This news raises several questions in people’s minds. The Center has banned 14 Fixed Dose Combination (FDC) drugs in the country with the statement that there is “no therapeutic justification” for these drugs and that they may involve a “risk” to people. People hit the search engine to get all the details about the news. What happened? What’s the whole deal? We will try to cover all the details of the news. Let’s continue the article.

List of prohibited fixed-dose combination drugs

According to the report, FDC drugs are those that maintain a combination of two more active pharmaceutical ingredients in a precise ratio. This decision came after suggestions from an experienced committee. The Ministry of Health has also issued a notification in this regard. These 14 fixed-dose combination medications including nimesulide and paracetamol dispersible tablets and chlorpheniramine maleate and codeine syrup are also on the list. Several things remain to tell you about the news, which you will find in the next section of the article.

Based on the ratio, FDC drugs are those that contain a combination of more APIs in a fixed or precise ratio. These banned drugs included those used to treat common problems of infection, fever and cough, combinations such as paracetamol nimesulide dispersible tablets, bromhexine amoxicillin and dextromethorphan bromhexine, ammonium chloride, menthol, promethazine and salbutamol bromhexine. Yes, these are some examples. The experienced committee mentioned that there is “no therapeutic justification for this FDC and the FDC possibly includes a risk to humans. Scroll down the page to read more about the news.

Further, in the great interest of the public, it is important that the manufacture, sale or dispensation of this FDC be prohibited under Section 26A of the Medicines and Cosmetics Act 1940. In view of the above, any type of regulation or limitation permitting any use in patients is not justifiable. According to the notification issued by the Ministry of Health on the basis of the recommendations of the expert committee and the technical advisory council on drugs, the central government welcomes that it is important and timely for the interest of the people to control by prohibiting manufacture for sale. We have done our best to include all the news details. Stay connected for more news.

.

Related Articles

Back to top button